Innovac Therapeutics
Edit info- Founded: 2022
- Location: Cambridge, MA
- Employee range: 11 - 50
- Clinical stage: RD
- Therapy area: Infectious
- Drug types: INF, ONC
- Lead product: INV001
- Funding: $18M Pre-A Aug 2023
- Investors: Elikon Venture, Vision Plus Capital, Yunion Healthcare Ventures, TG Sino-Dragon Fund
innovactx.com linkedin.com job board
Drug notes:
INV002 RD cancer; INV003 RD Infectious; INV004 RD cancer; INV005 RD infectious
About:
Innovac Therapeutics is developing innovative vaccines to meet unmet medical needs. mRNA vaccines have revolutionized the way diseases can be prevented and treated, however, there are still many ways in which the technology can be improved. Using their proprietary RNA technology platforms and manufacturing capabilities, Innovac is identifying mRNA that has high translation efficiency and stability that can then be encapsulated into lipid nanoparticles for targeted tissue delivery. Innovac is building a leading vaccine platform which their lead program, INV001 against infectious diseases.
Jobs:
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com